POLA+BR for Relapsed or Refractory DLBCL

Clinical trial NCT04535102 · WITHDRAWN

Trial details

NCT number: NCT04535102
Sponsor: University of Colorado, Denver
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2021-01-29
Primary completion: 2022-03-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.